Solventum, the healthcare company spun off from 3M earlier this year, has retained bankers to explore a sale of its ...

3M (MMM) stock gained nearly 5% Tuesday and is up another 3% Wednesday, making one of the best-performing best Dow Jones stocks so far this week. The upside comes as the Post-It note maker's first ...

Journey Medical said on Monday the U.S. Food and Drug Administration has approved its drug for the treatment of a long-term skin condition called rosacea, sending the company's shares up nearly 12 ...

The measures taken as a result of losing the deal include cutting staff, which would occur with immediate effect.

英为财情Investing.com - Supernus Pharmaceuticals (NASDAQ: SUPN)星期一发布了第三季度的财报，数据显示，公司营收高于分析师的预期，每股收益超出了分析师的预期。 在该公司发布的最新财报中，公司每股收益为$0.69，总营收为$175.69M，而此前英为财情Investing.com对分析师的调查显示，分析师预期该公司的营收为$157.3M，每股收益为 ...

With its vast readership of 12.4 million CEOs, CFOs, and decision-makers worldwide, the feature interview with Chairman, Professor Catharina Svanborg, underscores Hamlet BioPharma’s role in advancing ...

(Reuters) -3M Co raised its full-year profit forecast on Tuesday after strong demand for roofing material, industrial adhesives and electronics equipment helped the U.S. manufacturing giant ...

Revenue exceeded analyst estimates by 2.2%. Earnings per share (EPS) missed analyst estimates by 40%. Looking ahead, revenue ...

Bruce, Professional Relations Associate, 3M Pharmaceuticals, personal communication, March 2007). Of interest to us were the four subjects (15%) with reactions to fragrance mix. The positive ...

Reports Q3 revenue $175.7M, consensus $157.3M. The company said, “For the third quarter and first nine months of 2024, strong performance ...

In a report released today, Edward Tenthoff from Piper Sandler reiterated a Buy rating on Sutro Biopharma (STRO – Research Report), with ...